单一的氧气储存和受控释放,以改善对低氧瘤的光动力疗法
Long Yao1,2, Shaoqi Xie2, Yuqing Liu2
1Analysis and Testing Center, Nantong University, Nantong 226019, China.
概括
新的光动力疗法 (PDT) 策略利用化合物,在黑暗中储存和释放单片氧 (1O2),克服了传统PDT治疗瘤的局限性.
科学领域:
- 生物医学工程 生物医学工程
- 摄影化学的使用.
- 在瘤学瘤学.
背景情况:
- 光动力疗法 (PDT) 是一种有前途的,微创性癌症治疗方法.
- 关键的限制包括依赖外部光源和瘤缺氧.
- 需要新的策略来提高PDT在挑战性瘤微环境中的有效性.
研究的目的:
- 审查综合抗瘤药物的建设策略.
- 专注于使单个氧 (1O2) 储存和控制释放成为可能的化合物.
- 总结在低氧瘤和黑暗条件下PDT的性能.
主要方法:
- 审查有关1O2储存/释放单元的文献 (例如,2-皮里,炭,乙烯衍生物).
- 分析将这些单元与光敏剂或纳米载体集成的策略.
- 总结报告的PDT疗法对缺氧瘤的疗效数据.
主要成果:
- 能够储存和释放1O2的化合物可以实现暗 PDT.
- 与光敏感剂和纳米载体的整合策略对于药物输送至关重要.
- 这些先进的系统显示出治疗缺氧瘤的潜力.
结论:
- 集成的抗瘤药物与1O2储存/释放单元提供了一个有希望的替代传统PDT.
- 为高效的基于1O2的抗瘤系统提供了设计指南.
- 这种方法解决了光源依赖和瘤缺氧的挑战.
更多相关视频
相关概念视频
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


